We are live on ! Find out more
INBX

Inhibrx, Inc. Common Stock
INBX

Delisted

INBX was delisted on the 29th of May, 2024.

Back to rankings

99 hedge funds and large institutions have $548M invested in Inhibrx, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 40 increasing their positions, 28 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

146,350% more call options, than puts

Call options by funds: $2.93M | Put options by funds: $2K

43% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 28

2% less funds holding

Funds holding: 101 → 99 (-2)

11% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 18

46% less capital invested

Capital invested by funds: $1.01B → $548M (-$466M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
99
Holders Change
-2
Holders Change %
-1.98%
% of All Funds
1.56%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
16
Increased
40
Reduced
28
Closed
18
Calls
$2.93M
Puts
$2K
Net Calls
+$2.93M
Net Calls Change
-$2.27M

Top Buyers

Rank Fund Capital Flow
1
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
+$26.6M
2
State Street
State Street
Massachusetts
+$17.5M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$12.8M
4
PA
Perceptive Advisors
New York
+$11.2M
5
Morgan Stanley
Morgan Stanley
New York
+$5.82M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$35.3M
2
DGM
Darwin Global Management
Jersey
-$25.9M
3
TCM
Tybourne Capital Management
Hong Kong
-$5.96M
4
CS
Candriam SCA
Luxembourg
-$2.75M
5
SFM
Sphera Funds Management
Israel
-$2.71M
Name Holding Trade Value Shares
Change 		Change in
Stake
MWA
26
Meridian Wealth Advisors
Texas
$2.73M – – –
Wellington Management Group
27
Wellington Management Group
Massachusetts
$2.64M -$35.3M -1,381,018 -92%
Walleye Capital
28
Walleye Capital
New York
$2.46M +$1.4M +54,999 +99%
AllianceBernstein
29
AllianceBernstein
Tennessee
$2.29M -$212K -8,313 -7%
Victory Capital Management
30
Victory Capital Management
Texas
$2.16M +$434K +16,998 +20%
Rafferty Asset Management
31
Rafferty Asset Management
New York
$2.12M +$1.43M +56,121 +144%
PIM
32
Platinum Investment Management
Australia
$1.94M – – –
Bank of New York Mellon
33
Bank of New York Mellon
New York
$1.92M +$26K +1,017 +1%
N
34
Nuveen
North Carolina
$1.9M +$26K +1,019 +1%
Deutsche Bank
35
Deutsche Bank
Germany
$1.56M -$90.1K -3,528 -5%
Bank of America
36
Bank of America
North Carolina
$1.3M +$306K +11,977 +26%
Two Sigma Investments
37
Two Sigma Investments
New York
$1.29M +$1.47M +57,773 New
BC
38
Birchview Capital
Vermont
$1.12M +$267K +10,448 +26%
BG
39
Bellevue Group
Switzerland
$1.11M -$20.4K -800 -2%
State of Wisconsin Investment Board
40
State of Wisconsin Investment Board
Wisconsin
$802K – – –
D.E. Shaw & Co
41
D.E. Shaw & Co
New York
$802K +$566K +22,187 +161%
UBS Group
42
UBS Group
Switzerland
$721K -$118K -4,615 -12%
Susquehanna International Group
43
Susquehanna International Group
Pennsylvania
$716K -$323K -12,647 -28%
Voloridge Investment Management
44
Voloridge Investment Management
Florida
$701K +$803K +31,466 New
PPA
45
Parametric Portfolio Associates
Washington
$660K -$271K -10,629 -26%
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$633K +$84.2K +3,299 +13%
VIA
47
Vident Investment Advisory
Georgia
$600K +$115K +4,490 +20%
DekaBank Deutsche Girozentrale
48
DekaBank Deutsche Girozentrale
Germany
$590K +$61.3K +2,400 +10%
JP Morgan Chase
49
JP Morgan Chase
New York
$527K -$962K -37,702 -61%
JF
50
Jump Financial
Illinois
$508K +$197K +7,700 +51%
1
2
3 4 5

INBX Hedge Fund Activity: Q1 2022 in Review

99 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Inhibrx, Inc. Common Stock (INBX) for Q1 2022, worth a combined $548M — down 46% from $1.01B a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of INBX and 16 opened new positions — a net loss of 2 holders — while 28 trimmed existing stakes and 40 added.

The largest buyer was Loomis, Sayles & Company, opening a new position worth an estimated $26.6M. The largest seller was Wellington Management Group, cutting an estimated $35.3M.

  • 99 institutional investors held Inhibrx, Inc. Common Stock (INBX) as of Q1 2022, down from 101 in Q4 2021.
  • Funds reported $548M of Inhibrx, Inc. Common Stock stock for Q1 2022, down 46% quarter-over-quarter.
  • 16 funds opened new Inhibrx, Inc. Common Stock positions in Q1 2022 and 18 closed out, a net change of -2 holders.
  • The largest Inhibrx, Inc. Common Stock buyer in Q1 2022 was Loomis, Sayles & Company, an estimated $26.6M added.
  • The largest Inhibrx, Inc. Common Stock seller in Q1 2022 was Wellington Management Group, an estimated $35.3M sold.

Based on aggregated 13F filings for Q1 2022.